|
Investigation of the Prevalence Rate of Blastocystis sp. in Children with Cancer in Sanandaj City
|
Mojgan Shafiee1    , Leila Modiri 2, Mohammadbagher Khademerfan3 , Fares Bahrami4 |
1- PhD student, Department of Microbiology, Lahijan Branch, Islamic Azad University, Lahijan, Iran
2- Associate Professor, Department of Microbiology, Lahijan Branch, Islamic Azad University, Lahijan, Iran , leim_clinpathem@yahoo.com
3- Assistant Professor, Department of Parasitology and Mycology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran
4- Assistant Professor, Zoonoses Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran. |
|
|
Abstract: (961 Views) |
Background and Aim: Blastocystis sp. is a common intestinal protozoan that can infect humans and a wide range of animals such as mammals, birds, reptiles, and arthropods. The prevalence of Blastocystis species is relatively high in developing countries and has been reported as the most common parasite in Iran. In recent years, various studies have shown the importance of its pathogenicity in humans. Blastocystis sp. infection is associated with skin lesions and a variety of gastrointestinal disorders such as diarrhea and irritable bowel syndrome (IBS). The aim of this study was to evaluate the prevalence of Blastocystis sp. in children with cancer in Sananadaj City by PCR method.
Materials and Methods: To determine prevalence rate of Blastocystis sp infection in children with cancer, 93 fecal samples from available cancer patients were collected from the hospitals in Sananadaj City on the basis of census method from 2019 to 2021. The samples were analyzed by molecular method (PCR) using primers in the barcoding region of 18 rRNA gene for Blastocystis sp. amplification.
Results: The results of PCR showed 15 cases (16.1%) had 600 bp fragment for Blastocystis sp.Statistical analysis showed that Blastocystis sp.had no significant correlation with infection and residential place (Pvalue = 0. 48), age (Pvalue = 0.88) and contact to animals (Pvalue =0.83).
Conclusion: According to the results of this study, Blastocystis sp. is prevalent in cancer patients in Sananadaj city. These data can play an important role in the development of studies and research on Blastocystis sp. infections in cancer patients. In general, determination of the prevalence rate of the infection and identification of the different types of Blastocystis sp. in children with cancer and reporting these data to regional and national health officials can be beneficial in order to adopt a more appropriate treatment strategy and provide health strategies to control this infection.
|
|
| Keywords: Blastocystis, Prevalence rate, Cancer, Sananadaj |
|
|
Full-Text [PDF 1062 kb]
(289 Downloads)
|
Type of Study: Original Research |
Subject:
Parasitology and Mycology
Received: 2022/06/7 | Accepted: 2022/10/8 | Published: 2023/03/3
|
|
|
|
|
|
|
| References |
1. Ihejirika OC, Nwaorgu OC, Ebirim CI, Nwokeji CM. Effects of intestinal parasitic infections on nutritional status of primary children in Imo State Nigeria. Pan Afr Med J. 2019;33. [ DOI:10.11604/pamj.2019.33.34.17099] [ PMID] [ ] 2. Piperaki ET, Tassios PT. Parasitic infections: their position and impact in the postindustrial world. Clin Microbiol Infect. 2016;1;22(6):469-70. [ DOI:10.1016/j.cmi.2016.04.020] [ PMID] 3. Saki J, Amraee D. Prevalence of intestinal parasites among the rural primary school students in the west of Ahvaz county, Iran, 2015. Jentashapir J Health Res. 2017;28;8(1). [ DOI:10.5812/jjhr.40326] 4. Piperaki ET, Tassios PT. Parasitic infections: their position and impact in the postindustrial world. Clin Microbiol Infect. 2016;1;22(6):469-70. [ DOI:10.1016/j.cmi.2016.04.020] [ PMID] 5. Guilavogui T, Gantois N, Even G, Desramaut J, Dautel E, Denoyelle C, et al. Detection, Molecular Identification and Transmission of the Intestinal Protozoa Blastocystis sp. in Guinea from a Large-Scale Epidemiological Study Conducted in the Conakry Area. Microorganisms. 2022;15;10(2):446. [ DOI:10.3390/microorganisms10020446] [ PMID] [ ] 6. Dogruman-Al F, Simsek Z, Boorom K, Ekici E, Sahin M, Tuncer C, Kustimur S, Altinbas A. Comparison of methods for detection of Blastocystis infection in routinely submitted stool samples, and also in IBS/IBD Patients in Ankara, Turkey. PloS one. 2010;18;5(11):e15484. [ DOI:10.1371/journal.pone.0015484] [ PMID] [ ] 7. Salehi R, Haghighi A, Stensvold CR, Kheirandish F, Azargashb E, Raeghi S, Kohansal C, Bahrami F. Prevalence and subtype identification of Blastocystis isolated from humans in Ahvaz, Southwestern Iran. Gastroenterol Hepatol Bed Bench. 2017;10(3):235. 8. Abe N. Molecular and phylogenetic analysis of Blastocystis isolates from various hosts. Vet Parasitol. 2004;25;120(3):235-42. [ DOI:10.1016/j.vetpar.2004.01.003] [ PMID] 9. Parija SC, Jeremiah SS. Blastocystis: Taxonomy, biology and virulence. Trop Parasitol. 2013;3(1):17. [ DOI:10.4103/2229-5070.113894] [ PMID] [ ] 10. Mukku KK, Raju S, Yelanati R. Refractory giardiasis in renal transplantation: a case report. Nephrology. 2015;1;20(1):44. [ DOI:10.1111/nep.12336] [ PMID] 11. Wawrzyniak I, Poirier P, Viscogliosi E, Dionigia M, Texier C, Delbac F, Alaoui HE. Blastocystis, an unrecognized parasite: an overview of pathogenesis and diagnosis. Ther Adv Infect Dis. 2013;1(5):167-78. [ DOI:10.1177/2049936113504754] [ PMID] [ ] 12. Santín M, Gómez-Muñoz MT, Solano-Aguilar G, Fayer R. Development of a new PCR protocol to detect and subtype Blastocystis spp. from humans and animals. Parasitol Res. 2011;109(1):205-12. [ DOI:10.1007/s00436-010-2244-9] [ PMID] 13. Mahni MB, Rezaeian M, Eshrat Beigom KI, Raeisi A, Khanaliha K, Tarighi F, Kamranrashani B. Prevalence of intestinal parasitic infections in Jiroft, Kerman Province, Iran. Iran J Parasitol. 2016;11(2):232 14. Klastersky J, Aoun M. Opportunistic infections in patients with cancer. Ann Oncol. 2004;1;15:iv329-35. [ DOI:10.1093/annonc/mdh947] [ PMID] 15. Bahrami F, Haghighi A, Khadem-Erfan MB, Zamini G. Diagnostic accuracy of intestinal parasitic infections in individuals admitted to medical laboratories. Iran J Public Health. 2018;23;47(4):620-2. 16. Scicluna SM, Tawari B, Clark CG. DNA barcoding of Blastocystis. Protist. 2006;28;157(1):77-85. [ DOI:10.1016/j.protis.2005.12.001] [ PMID] 17. Kumarasamy V, Roslani AC, Rani KU, Govind SK. Advantage of using colonic washouts for Blastocystis detection in colorectal cancer patients. Parasit Vector. 2014;7(1):1-5. [ DOI:10.1186/1756-3305-7-162] [ PMID] [ ] 18. Mülayim S, Aykur M, Dağcı H, Dalkılıç S, Aksoy A, Kaplan M. Investigation of isolated Blastocystis subtypes from Cancer patients in Turkey. Acta Parasitol. 2021;66(2):584-92. [ DOI:10.1007/s11686-020-00322-y] [ PMID] 19. Zhang W, Ren G, Zhao W, Yang Z, Shen Y, Sun Y, Liu A, Cao J. Genotyping of Enterocytozoon bieneusi and subtyping of Blastocystis in cancer patients: relationship to diarrhea and assessment of zoonotic transmission. Front Microbiol. 2017;21;8:1835. [ DOI:10.3389/fmicb.2017.01835] [ PMID] [ ] 20. Asghari A, Zare M, Hatam G, Shahabi S, Gholizadeh F, Motazedian M. Molecular identification and subtypes distribution of Blastocystis sp. isolated from children and adolescent with cancer in Iran: evaluation of possible risk factors and clinical features. Acta Parasitol. 2020;65(2):462-73. [ DOI:10.2478/s11686-020-00186-2] [ PMID] 21. Esteghamati A, Khanaliha K, Bokharaei-Salim F, Sayyahfar S, Ghaderipour M. Prevalence of intestinal parasitic infection in cancer, organ transplant and primary immunodeficiency patients in Tehran, Iran. Asian Pac J Cancer Prev. 2019;20(2):495. [ DOI:10.31557/APJCP.2019.20.2.495] [ PMID] [ ] 22. Rasti S, Hassanzadeh M, Hooshyar H, Momen-Heravi M, Mousavi SG, Abdoli A. Intestinal parasitic infections in different groups of immunocompromised patients in Kashan and Qom cities, central Iran. Scand J Gastroenterol. 2017;3;52(6-7):738-41. [ DOI:10.1080/00365521.2017.1308547] [ PMID] 23. Poirier P, Wawrzyniak I, Albert A, El Alaoui H, Delbac F, Livrelli V. Development and evaluation of a real-time PCR assay for detection and quantification of Blastocystis parasites in human stool samples: prospective study of patients with hematological malignancies. J Clin Microbiol. 2011;49(3):975-83. [ DOI:10.1128/JCM.01392-10] [ PMID] [ ] 24. Solomayer EF, Feuerer M, Bai L, Umansky V, Beckhove P, Meyberg GC, Bastert G, Schirrmacher V, Diel IJ. Influence of adjuvant hormone therapy and chemotherapy on the immune system analysed in the bone marrow of patients with breast cancer. Clin Cancer Res. 2003;1;9(1):174-80. 25. Öner TÖ, Karabey M, Can H, Döşkaya AD, Karakavuk M, Gül A, Köseoğlu AE, Döşkaya M, Ün C, Gürüz AY, Kaya S. Molecular investigation of Blastocystis sp. and its subtypes in cancer patients under chemotherapy in Aegean region, Turkey. Acta Trop. 2022 ;26:106577. [ DOI:10.1016/j.actatropica.2022.106577] [ PMID] 26. Kahish RS, Alghasi A, Hadadi S, Nasab MA, Mafakherzadeh A. The Prevalence of Blastocystis Infection in Pediatric Patients with Malignancy: A Single-Center Study in Ahvaz, Iran. Arch Pediatr Infect Dis. 2021;30;9(2). [ DOI:10.5812/pedinfect.104068] 27. Bahrami F, Haghighi A, Zamini G, Khademerfan M. Molecular evidence for zoonotic transmission of Blastocystis subtypes in Kurdistan province, West of Iran. Ann Parasitol. 2020;66(1). 28. Jalallou N, Meamar AR. Frequency of Blastocystis among Malignant patients in comparison with control group. Paramedical Sciences and Military Health. 2017;10;12(3):17-22. 29. Kołodziejczyk L, Adamska M, Skotarczak B, Jaczewska S, Safranow K, Bielicki P, et al. Colorectal cancer and Blastocystis sp. infection. Parasit Vector. 2021;14:200 [ DOI:10.1186/s13071-021-04681-x] [ PMID] [ ] 30. Fontanelli Sulekova L, Gabrielli S, Furzi F, Milardi GL, Biliotti E, De Angelis M, Iaiani G, Fimiani C, Maiorano M, Mattiucci S, Taliani G. Molecular characterization of Blastocystis subtypes in HIV-positive patients and evaluation of risk factors for colonization. BMC Infect. Dis. 2019;19(1):1-7. [ DOI:10.1186/s12879-019-4537-7] [ PMID] [ ] |
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
|
Ethics code: IR.IAU.LIAU.REC.1401.021
|
